Back

BITC induces cardiomyocyte proliferation and heart regeneration

Sakaguchi, A.; Kawasaki, M.; Murata, K.; Masumoto, H.; Kimura, W.

2021-09-09 pharmacology and toxicology
10.1101/2021.09.08.459197 bioRxiv
Show abstract

Cardiomyocyte proliferation is an evolutionarily conserved mechanism that supports cardiac regeneration in vertebrates. Mammalian cardiomyocytes are arrested from the cell cycle shortly after birth, and therefore mammals lose the ability to regenerate injured myocardium for the rest of their lives. Pharmacological induction of cardiomyocyte proliferation has gained a lot of interest in recent years, as researchers strive to achieve heart tissue regeneration. Here we show that a small chemical, benzyl isothiocyanate (BITC), induced cardiomyocyte proliferation through activation of the cyclin-dependent kinase (CDK) pathway. BITC treatment also allowed heart regeneration in the infarcted neonatal heart, even after the regeneration period in mice. Furthermore, administration of BITC to adult mice in parallel with mild hypoxia (10% O2) induced cell cycle reentry and tissue regeneration in the adult heart. Our findings thus suggest that pharmacological activation of the CDK pathway using BITC, concurrently with the activation of hypoxia-related signaling pathways, may be a promising approach to inducing cardiac regeneration in patients with heart disease.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Journal of Molecular and Cellular Cardiology
40 papers in training set
Top 0.1%
11.8%
2
Stem Cells Translational Medicine
13 papers in training set
Top 0.1%
9.6%
3
npj Regenerative Medicine
24 papers in training set
Top 0.1%
6.7%
4
PLOS ONE
5266 papers in training set
Top 29%
5.4%
5
Scientific Reports
3612 papers in training set
Top 17%
5.4%
6
Cell Proliferation
12 papers in training set
Top 0.1%
4.3%
7
Journal of Cellular and Molecular Medicine
20 papers in training set
Top 0.1%
4.0%
8
eLife
5828 papers in training set
Top 34%
3.2%
50% of probability mass above
9
Biomedicine & Pharmacotherapy
42 papers in training set
Top 0.3%
3.2%
10
Circulation Research
47 papers in training set
Top 0.6%
2.4%
11
Journal of the American Heart Association
140 papers in training set
Top 2%
2.4%
12
Biomedicines
67 papers in training set
Top 0.8%
2.1%
13
Pharmacological Research
18 papers in training set
Top 0.1%
1.9%
14
Cell Death & Disease
126 papers in training set
Top 1%
1.9%
15
Toxicological Sciences
41 papers in training set
Top 0.3%
1.7%
16
Circulation
74 papers in training set
Top 1%
1.7%
17
Frontiers in Cardiovascular Medicine
53 papers in training set
Top 2%
1.7%
18
JACC: Basic to Translational Science
21 papers in training set
Top 0.4%
1.7%
19
Stem Cell Reports
130 papers in training set
Top 1%
1.5%
20
International Journal of Molecular Sciences
494 papers in training set
Top 9%
1.5%
21
British Journal of Pharmacology
40 papers in training set
Top 0.6%
1.1%
22
Toxicology and Applied Pharmacology
14 papers in training set
Top 0.2%
1.0%
23
Nature Communications
5641 papers in training set
Top 54%
1.0%
24
Cell Death Discovery
58 papers in training set
Top 1%
0.9%
25
Development
497 papers in training set
Top 5%
0.8%
26
Frontiers in Neuroscience
256 papers in training set
Top 6%
0.8%
27
FASEB BioAdvances
18 papers in training set
Top 0.4%
0.8%
28
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 45%
0.6%
29
Frontiers in Pharmacology
111 papers in training set
Top 4%
0.6%
30
Journal of Personalized Medicine
28 papers in training set
Top 2%
0.6%